Is Methocarbamol safe for babies and kids?
Moderate risk for kidsInfants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Methocarbamol poses heightened risk.
What is methocarbamol?
The IUPAC name is [2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate.
Also known as: [2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate, Robaxin, Metocarbamol, Miolaxene.
- IUPAC name
- [2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
- CAS number
- 532-03-6
- Molecular formula
- C11H15NO5
- Molecular weight
- 241.24 g/mol
- SMILES
- COC1=CC=CC=C1OCC(COC(=O)N)O
- PubChem CID
- 4107
Risk for babies
Moderate riskInfants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Methocarbamol poses heightened risk.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Elevated riskMethocarbamol poses pregnancy risk through potential teratogenicity, altered pharmacokinetics (increased blood volume, changed CYP activity), and placental transfer. FDA pregnancy category should be evaluated.
Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.
Regulatory consensus
1 regulatory bodyhas classified Methocarbamol.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| US FDA (approved drug; non-scheduled; veterinary NADA) | 2021 | no carcinogenicity classification; FDA-approved muscle relaxant (Robaxin) and veterinary drug (Robaxin-V for dogs/horses); not a DEA controlled substance; not classified for carcinogenicity by NTP, IARC, or EFSA |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter methocarbamol
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Methocarbamol:
-
Alternative drug class; Non-pharmacological therapy; Lowest effective dose
Trade-offs: Direct chemical substitution requires verification that the replacement does not introduce new hazards (regrettable substitution). Conduct full hazard assessment of proposed alternative before adoption.Relative cost: 1.2-2×
Frequently asked questions
Is methocarbamol safe for kids?
Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Methocarbamol poses heightened risk.
What products contain methocarbamol?
Methocarbamol appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
What should I do if my child is exposed to methocarbamol?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
See Methocarbamol in the baby app
Look up products containing methocarbamol, compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (1)
- FDA Methocarbamol Robaxin Prescribing Information 2021: Not Controlled Substance; Guaifenesin Carbamate Ester; Not TCA No Anticholinergic; Robaxin-V NADA Dogs Horses Tetanus 44–220 mg/kg IV; Pediatric Tetanus Use; No Carcinogenicity Classification (2021) — regulatory
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →